The global drug-eluting balloon catheters market size is calculated at US$ 1.42 billion in 2024, grew to US$ 1.58 billion in 2025, and is projected to reach around US$ 4.02 billion by 2034. The market is expanding at a CAGR of 11.1% between 2025 and 2034.
Numerous leaders are leveraging their position in the global market to invest in the development of novel therapies and the latest solutions for severe conditions.
In April 2025, Cordis, a leading player in interventional cardiovascular and endovascular technologies, announced new data from two important peripheral studies that are assessing the SELUTION SLR™ Drug-Eluting Balloon (DEB). Dr. Michael Lichtenberg, Chief of Interventional Angiology, said that this approach will deliver unequivocal clinical advantages in complex patient cohorts.
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com